key: cord-0937930-dfrvnsk4 authors: Alexander, Marina R.; Rootes, Christina L.; van Vuren, Petrus Jansen; Stewart, Cameron R. title: Concentration of infectious SARS-CoV-2 by polyethylene glycol precipitation date: 2020-09-23 journal: J Virol Methods DOI: 10.1016/j.jviromet.2020.113977 sha: 7f3bb4c0c70a92dced371117d63c8692fc8d404e doc_id: 937930 cord_uid: dfrvnsk4 The development of medical countermeasures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires robust viral assays. Here we have adapted a protocol for polyethylene glycol (PEG)-mediated precipitation of SARS-CoV-2 stocks without the need for ultracentrifugation. Virus precipitation resulted in a ∼1.5 log(10) increase in SARS-CoV-2 titres of virus prepared in VeroE6 cells and enabled the infection of several immortalized human cell lines (Caco-2 and Calu-3) at a high multiplicity of infection not practically achievable without virus concentration. This protocol underscores the utility of PEG-mediated precipitation for SARS-CoV-2 and provides a resource for a range of coronavirus research areas. Coronaviridae) is the causative agent of the current coronavirus disease pandemic. Since emerging in Wuhan, Hubei province, China in December 2019 [1] , SARS-CoV-2 has spread across the globe, causing an estimated (as of 3 August 2020) 17.7 million infections and over 680,000 deaths [2] . There are currently no FDA-approved medicines or therapies available to treat COVID-19, with most mitigation strategies focused on physical distancing and other public health measures [3] . According to the World Health Organisation there are over 120 vaccine candidates currently in various stages of development [4] . The development of several countermeasures against COVID-19, including antiviral compound screening, vaccine virus production and host-virus interactive studies, are reliant on robust viral assays that can be rapidly implemented in diverse laboratory settings. SARS-CoV-2 is often propagated in African green monkey kidney epithelial (VeroE6) cells for several reasons, including visible cytopathic effect and the VeroE6 deficiency in type I interferon secretion [5] , which allows the virus to grow to higher titres. The tropism and replication kinetics of SARS-CoV-2 has been investigated in a range of primary and immortalized cell lines (both animal and human) [6] , and while SARS-CoV-2 replication is observed in several immortalized human cell lines High molecular weight polyethylene glycol-6000 (PEG) has been used for the concentrating of virus samples for decades. Initially developed for arbovirus [7] and bacteriophage purification [8] , PEG precipitation has subsequently been adapted to many RNA viruses including influenza virus (Orthomyxoviridae) [9] , respiratory syncytial virus (Paramyxoviridae) [10] and HCoV-229E coronavirus (Coronaviridae) [11] . While there are several alternative approaches for virus concentration, including ultracentrifugation, PEG precipitation is appealing due to its simplicity and the precipitation of virus in low-temperature, high-salt environment that stabilizes viral particles and produces a carrier medium that is isotonic to cells. Given that infectious SARS-CoV-2 is handled at high containment, it is important that research protocols are compatible with constraints of working in a physical containment (PC)-3 or PC-4 laboratory. This method describes SARS-CoV-2 propagated in VeroE6 cells (ATCC CRL-1586) that were maintained as described previously [12] . All virology work was conducted The infectious titres of SARS-CoV-2 stocks, both before and after PEG-precipitation, was determined by TCID50 assays performed as described previously [13] . Samples were titrated in quadruplicate in 96-well plates, co-cultured with VeroE6, Caco-2 or Calu-3 cells for four days. VeroE6 cells and Calu-3 cells displayed cytopathic effect, consistent with previous findings (Figure 1 ). As cytopathic effect was not observed in Caco-2 cells, virus titres were measured by immunofluorescence (Figure 2 ). For this, cells were fixed for 30 minutes in 4 % paraformaldehyde (PFA) and stained with a polyclonal antibody targeting the SARS-CoV-2 Nucleocapsid (N) protein (Jomar J o u r n a l P r e -p r o o f Sciences, catalog number: 40588-T62, used at 1/2,000) for 1 hour. Cells were subsequently stained with 1/1,000 dilution of an anti-rabbit AF488 antibody (Invitrogen catalog number A110008). Nuclei were counter-stained with DAPI. Cells were imaged using the CellInsight quantitative fluorescence microscope (Thermo Fisher Scientific) at a magnification of 10 x, 49 fields/well, capturing the entire well. The infectious titre for all three cell types was calculated by the method of Reed and Muench [14] . Unconcentrated virus titres were highest in VeroE6 cells, followed by A Novel Coronavirus from Patients with Pneumonia in China Coronavirus disease (COVID-19) Situation Report -196 Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak Draft Landscape of COVID-19 candidate vaccines -31 Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study A simple method for concentration of arboviruses propagated in tissue culture Rapid bacteriophage sedimentation in the presence of polyethylene glycol and its application to large-scale virus purification Polyethylene glycol purification of influenza virus with respect to aggregation and antigenicity Purification of human respiratory syncytial virus by ultracentrifugation in iodixanol density gradient Human Coronavirus 229E Remains Infectious on Common Touch Surface Materials. mBio Promotion of Hendra virus replication by microRNA 146a Promotion of Hendra virus replication by microRNA 146a A simple method of estimating fifty percent endpoints Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR The authors wish to thank Shuning Shi, Tamara Gough and Kerri Bruce assistance robust assays for medical countermeasure development. This simple protocol can readily be scaled up and deployed to aid antiviral screening programmes.